当前位置: X-MOL 学术Ann. Review Paleopathol. Mech. Disease › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Long Noncoding RNAs and Human Liver Disease
Annual Review of Pathology: Mechanisms of Disease ( IF 36.2 ) Pub Date : 2022-01-24 , DOI: 10.1146/annurev-pathol-042320-115255
Johanna K DiStefano 1 , Glenn S Gerhard 2
Affiliation  

Long noncoding RNAs (lncRNAs) are pervasively transcribed in the genome, exhibit a diverse range of biological functions, and exert effects through a variety of mechanisms. The sheer number of lncRNAs in the human genome has raised important questions about their potential biological significance and roles in human health and disease. Technological and computational advances have enabled functional annotation of a large number of lncRNAs. Though the number of publications related to lncRNAs has escalated in recent years, relatively few have focused on those involved in hepatic physiology and pathology. We provide an overview of evolving lncRNA classification systems and characteristics and highlight important advances in our understanding of the contribution of lncRNAs to liver disease, with a focus on nonalcoholic steatohepatitis, hepatocellular carcinoma, and cholestatic liver disease.

中文翻译:


长链非编码 RNA 与人类肝病

长链非编码 RNA (lncRNA) 在基因组中广泛转录,具有多种生物学功能,并通过多种机制发挥作用。人类基因组中 lncRNA 的绝对数量引发了关于它们在人类健康和疾病中的潜在生物学意义和作用的重要问题。技术和计算的进步使大量 lncRNA 的功能注释成为可能。尽管近年来与 lncRNA 相关的出版物数量有所增加,但关注肝脏生理学和病理学方面的出版物相对较少。我们概述了不断发展的 lncRNA 分类系统和特征,并强调了我们在理解 lncRNA 对肝病的贡献方面取得的重要进展,重点是非酒精性脂肪性肝炎,

更新日期:2022-01-25
down
wechat
bug